IPRIPR2017-01912Institution Denied
FRESENIUS KABI USA, LLCv.AstraZeneca AB
IPR challenge of US 8466139.
Type
IPR
Filed
Aug 4, 2017
Instituted
Dec 11, 2017
Decided
—
Patent
Application
13602667
Inventor
John R. Evans et al
Granted
Jun 18, 2013
01
Timeline
2 milestones
2017-08-04Petition filed
2017-12-11Institution
02
Parties & counsel
Petitioner
FRESENIUS KABI USA, LLC
Counsel
Aly, Imronet al
Patent Owner
AstraZeneca AB
Counsel
Prugo, Filkoet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →